Skip to Content

Rozerem Approval History

FDA Approved: Yes (First approved July 22, 2005)
Brand name: Rozerem
Generic name: ramelteon
Dosage form: Tablets
Company: Takeda Pharmaceuticals North America, Inc.
Treatment for: Insomnia

Rozerem (ramelteon) is an orally active hypnotic indicated for the treatment of insomnia characterized by difficulty with sleep onset.

Development History and FDA Approval Process for Rozerem

DateArticle
Jul 22, 2005Approval Rozerem Takeda Pharmaceuticals North America, Inc. - Treatment for Insomnia
Sep 24, 2004Takeda Submits New Drug Application for Ramelteon, an Investigational Sleep Drug

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide